In the context of cancer, disruptions in genomic imprinting can lead to the misregulation of imprinted genes, which in turn can contribute to tumorigenesis. For instance, the loss of imprinting (LOI) can result in the activation of oncogenes or the inactivation of tumor suppressor genes. This disruption can occur due to genetic mutations, environmental factors, or errors during cell division.
